The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas
Journal of Clinical Oncology (JCO) Podcast · Journals Online Team
May 30, 20137m 18s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This podcast provides observations and commentary on the JCO article,"Results of an international randomized phase 3 trial of the mTOR inhibitor, ridaforolimus, versus placebo to control metastatic sarcomas in patients following benefit from prior chemotherapy" by authors George Demetri, et al.